1st Edition
by Debmalya Barh (Editor), Kenneth Lundstrom (Editor)
The
COVID-19 pandemic has affected the entire world in an unprecedented way
and this book provides an overview of the historical facts as well as
ongoing approaches to tackle the COVID-19 pandemic. Experts of the
respective domains provide details on anti-SARS-COV-2 drug strategies,
including repurposing drugs used for other indications and development
of novel drugs looking at different approaches to target virus entry and
replication. COVID-19 vaccine development based on inactivated and
attenuated live virus, protein subunit and peptide-based vaccines and
utilization of vaccine candidates based on viral vectors, DNA and RNA
are presented for both preclinical studies and clinical trials.
Key Features
•
Explains the background of the COVID-19 pandemic, the current progress
in the development of treatments and prevention of COVID-19 including
future aspects of dealing with pandemics.
• Serves as a timely repository of knowledge on COVID-19 for researchers and medical professionals engaged in its management.
• Features the patent aspects of COVID-19.
